WebObjective Evaluation of toxicity and outcome of high-risk gestational trophoblastic neoplasia when treated with EP-EMA (etoposide, 150 mg/m 2; cisplatin, 75 mg/m 2, … Web Day 1 - Paclitaxel 135 mg/m 2 over 3 hours+Etoposide 150 mg/m 2 over 30 minutes. Day 15 - Paclitaxel 135 mg/m 2 over 3 hours+Cisplatin 75 mg/m 2 over 1 hour.
UpToDate
WebObjective: Evaluation of toxicity and outcome of high-risk gestational trophoblastic neoplasia when treated with EP-EMA (etoposide, 150 mg/m; cisplatin, 75 mg/m, intravenous, … WebNov 29, 2024 · - EMA-EP for GTN - Chemotherapy outcomes for high-risk GTN - Chemotherapy outcomes in stage IV GTN; RELATED TOPICS. COVID-19: Considerations in patients with cancer ... The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia. Eur J Cancer … sheraz horse
EMA-EP regimen, as firstline multiple agent chemotherapy in high …
WebAug 26, 2008 · Dose reduction was necessary to decrease the incidence of hematotoxicity and hepatoxicity. After treatment she remained in complete remission and delivered a term healthy baby following our regimen several years later. It seems concurrent multiagent, EMA-EP chemotherapy and whole brain irradiation with craniotomy is possible in … WebJan 4, 2014 · The favored regimen is EMA-EP (etoposide, methotrexate, actinomycin-D, etoposide, cisplatin) [2•]. Table 1. Salvage chemotherapy for resistant or relapsed gestational trophoblastic neoplasia ... The use of newer chemotherapy agents such as paclitaxel and gemcitabine [14, 15], or high-dose chemotherapy with or without … WebOct 20, 2024 · However, some investigators omit the cranial radiation, relying on replacement of the standard dose of methotrexate in the EMA/CO regimen with the higher dose of 1,000 mg/m 2 IV for 24 hours on the first day, as noted above, ... Sun Z, Wan X, et al.: EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. J … springwood shopping centre gawler